期刊文献+

经尿道2μm激光膀胱部分切除术治疗膀胱尿路上皮癌组织病理学分析 被引量:7

Histopathologic analysis of 2 micron continuous wave laser for the partial cystectomy of bladder urothelial carcinoma
原文传递
导出
摘要 目的观察应用2μm激光行经尿道行膀胱部分切除术治疗膀胱肿瘤的组织病理学特点。方法2007年10月至2008年12月采用经尿道膀胱镜行2μm激光膀胱部分切除术治疗54例膀胱肿瘤患者,男性41例,女性13例,年龄27—81岁,平均(66.2±12.4)岁;共有肿瘤65个。术中全层汽化切割瘤体周围膀胱壁至膀胱壁最外层的疏松结缔组织,将切取的全层标本送病理检查。观察术后组织形态学改变。结果54例患者均可耐受手术。术后肿瘤临床分期:T1期42例,T2期12例。术后随访1—14个月,平均8.5个月,复发2例,无原位复发。组织病理学示瘤体及其附着的膀胱黏膜、黏膜下层及全部肌层完整切除,切缘无残留,标本可清楚判定肿瘤分期。术后1周手术创面呈凹陷状,为纤维结缔组织伴慢性炎细胞浸润;术后1个月创面凹陷变浅,并出现移行上皮细胞覆盖,其下为纤维结缔组织;至术后3个月创面凹陷基本消失,黏膜稍苍白;术后6个月观察创面黏膜与周围膀胱壁黏膜基本一致。结论2μm激光治疗膀胱肿瘤可达到膀胱部分切除术的临床效果,肿瘤及萁附着的陪胱壁伞肌.屡可完整切除.所得标本可准确判守肿瘤的临床分期.术后创面恢复良好。 Objective To observe the histopathologic characteristics of 2 micron continuous wave laser transurethral partial cystectomy for the treatment of bladder tumor. Methods A total of 54 patients with 65 bladder tumors underwent 2 micron laser via transurethral by caudal or surface anesthesia from October 2007 to December 2008. It included 41 male and 13 female cases, and the age ranged from 27 to 81 years old with a mean of (66. 2 ± 12. 4) years old. The operation evaporated and exsected the wall of urinary bladder, including tumor, submucosa and all muscular layers. Specimens were sent for pathology examination. The histomorphologic changes of raw surfaces were observed 1 week, 1 month, 3 months, 6 months and 1 year postoperation by cystoscopic and pathologic examinations. Results All the patients tolerated in the operation. Clinical stages of the tumor: T1 for 42 cases, T2 for 12 cases. All cases were followed-up for 1 to 14 months, with a mean of 8.5 months. Tumor recurrences were found in 2 cases, no one had recurrence in situ. The tumor, submucosa and all muscular layers can be resected completely by 2 micron continuous wave laser transurethral partial cystectomy. Pathologic staging can be judged correctly. The umbilication raw surface were infiltrated by fibrous connective tissue and chronic inflammatory cells 1 week postoperation. The umbilication changed shallow and transitional epithelial cells began to cover it 1 month postoperation. The umbilication dispeared and transitional epithelial cells cover the raw surface 3 months postoperation. There was no difference between the raw surface and normal bladder mucosa. Conclusions 2 micron continuous wave laser for the treatment of bladder tumor can get the same clinical result as partial cystectomy. The pathologic staging can be judged correctly by the specimens.
出处 《中华外科杂志》 CAS CSCD 北大核心 2009年第20期1566-1568,共3页 Chinese Journal of Surgery
关键词 膀胱肿瘤 膀胱镜检查 激光 病理学 Urinary bladder noeplasms Cystoscopy Lasers Pathology
  • 相关文献

参考文献6

二级参考文献18

  • 1徐月敏,张炯,金重睿,撒应龙,张心如,陈嵘,谢弘,李涛,司捷旻.KTP激光汽化术治疗良性前列腺增生[J].中华泌尿外科杂志,2004,25(9):631-633. 被引量:85
  • 2洪宝发,蔡伟,符伟军,杨勇,王威,陈耀富,展洁,张翠娥,李炎唐,崔胜堂.选择性绿激光汽化术治疗良性前列腺增生的临床研究[J].中华泌尿外科杂志,2005,26(1):17-19. 被引量:90
  • 3洪宝发,符伟军,蔡伟,杨勇,陈耀富,展洁,张翠娥.经尿道选择性绿激光前列腺汽化术治疗高龄高危良性前列腺增生[J].中华泌尿外科杂志,2006,27(1):43-45. 被引量:128
  • 4金重睿,徐月敏,吴登龙,撒应龙,陈宾峰.绿激光汽化治疗浅表性膀胱肿瘤[J].临床泌尿外科杂志,2007,22(5):343-344. 被引量:45
  • 5Uchida T,Ohori M,Soh S,et al.Factors influencing morbidity in patients undergoing transurethral resection of the prostate.Urology,1999 ,53:98-105.
  • 6Anson K.Could the latest generation potassium titanyl phosphate lasers be the ones to make transurethral resection of the prostate an operation of historical interest only? Curr Opin Urol,2004,14:27-29.
  • 7Shingleton WB,Terrell F,Renfroe L,et al.Low-power vs high-power KTP laser:improved method of laser ablation of prostate.J Endourol,1999,13:49-52.
  • 8Hai MA,Malek RS.Photoselective vaporization of the prostate :initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia.J Endourol,2003 ,17 :93-96.
  • 9Reich O,Bachmann A,Schneede P,et al.Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate.J Urol,2004,171 (6 Pt1) :2502-2504.
  • 10Malek RS,Kuntzman RS,Barrett DM.High power potassium-titanyl-phosphate laser vaporization prostatectomy.J Urol,2000,163:1730-1733.

共引文献184

同被引文献67

  • 1何万兵,陈卫国.钬激光治疗膀胱肿瘤的临床体会[J].西南军医,2007,9(2):55-55. 被引量:1
  • 2Knowles MA. The genetics of transitional cell carcinoma : progress and potential clinical application. BJU Int, 1999,84:412-427.
  • 3Dunst J, Sauer R, Schrott KM. Organ-sparing treatment of advanced bladder cancer:a 10-year experience. Int J Radiat Oncol Biol Phys, 1994,30:261-266.
  • 4Scher HI, Yagoda A, Herr HW, et al. Neoadjuvant M-VAC ( methotrexate,vinblastine,doxorubicin and cisplatin) effect on the primary bladder lesion. J Urol, 1988,139:470-474.
  • 5Epstein JI, Amin MB, Reuter VR, et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial ( transitional cell ) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol, 1998,22 : 1435-1448.
  • 6Yang Y, Wei ZT, Zhang X, et al. Transurethral Partial Cystectomy with Continuous Wave Laser for Bladder carcinoma. J Urol,2009, 182:66-69.
  • 7Pietrow PK, Smith JA Jr. Laser treatment for invasive and noninvasive carcinoma of the bladder. J Endourol,2001,15:415- 418.
  • 8Herr HW. Transurethral resection of muscle-invaslve bladder cancer: 10-year outcome. J Clin Oncol, 2001,19 : 89-93.
  • 9Perdona S, Autorino R, Damiano R, et al. Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer:a muhi-institutianal, long-term experience. Cancer, 2008, 112 : 75-83.
  • 10Van Der Heijden A G, Witjes J A. Recurrence, progres- sion, and follow-up in non-muscle-invasive bladder canc- er[J]. Eur Urol Suppl, 2009,8(7) :556-562.

引证文献7

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部